Industry3h ago
Industry
Nestle Uses AI To Target Weight-Loss Drug Users
Millions of consumers using GLP-1 drugs like Ozempic now drive a new product strategy at Nestle. The company combines artificial intelligence with nutritional science to design specialized food for these patients. This pivot attempts to offset potential revenue losses from reduced calorie intake. It shows how food giants leverage AI for niche market segmentation.